Home › Diffuse Scleroderma › Arizona › Phoenix
Diffuse Scleroderma clinical trials in Phoenix, AZ
3 studies for Diffuse Scleroderma are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RecruitingPhase 2
- EncompaSSc site in Phoenix, AZ, Phoenix
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Mayo Clinic, Phoenix
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Phoenix, Phoenix
Diffuse Scleroderma trials in other cities
- New York City, NY8 studies
- Chicago, IL7 studies
- Ann Arbor, MI7 studies
- Durham, NC6 studies
- Los Angeles, CA6 studies
- Baltimore, MD5 studies
- Houston, TX5 studies
- Boston, MA5 studies
- Pittsburgh, PA4 studies
- Kansas City, KS4 studies
- New Orleans, LA4 studies
- Philadelphia, PA4 studies
Other studies in Phoenix
- Colorectal Cancer25 studies
- Breast Cancer25 studies
- Obesity23 studies
- Metastatic Cancer20 studies
- Non-Small Cell Lung Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Pancreatic Cancer17 studies
- Multiple Myeloma16 studies
- Cardiovascular Disease16 studies
- Overweight15 studies
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.